Estrella Immunopharma Warrant
ESLAW
10 hedge funds and large institutions have $4.65M invested in Estrella Immunopharma Warrant in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
43% more funds holding
Funds holding: 7 → 10 (+3)
3% more capital invested
Capital invested by funds: $4.52M → $4.65M (+$130K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$22.4K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$3.35K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$99 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $2M | +$3.35K | +6,800 | +3% |
|
|
ASM
2
ATW SPAC Management
New York
| $1.93M | – | – | – |
|
|
RCM
3
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
| $496K | – | – | – |
|
|
KPF
4
K2 Principal Fund
Toronto,
Ontario, Canada
| $72K | – | – | – |
|
|
CH
5
CVI Holdings
Wilmington,
Delaware
| $44K | – | – | – |
|
6
D.E. Shaw & Co
New York
| $44K | – | – | – |
|
|
7
Hudson Bay Capital Management
Stamford,
Connecticut
| $39K | -$2.27K | -4,600 | -6% |
|
|
WA
8
Whitebox Advisors
Minneapolis,
Minnesota
| $23K | +$22.4K | +45,476 | New |
|
|
SAMU
9
SONA Asset Management (US)
New York
| $2K | +$1.74K | +3,540 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| – | +$99 | +200 | New |
|
ESLAW Hedge Fund Activity: Q4 2021 in Review
10 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q4 2021, worth a combined $4.65M — up 2.9% from $4.52M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ESLAW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Whitebox Advisors, opening a new position worth an estimated $22.4K. The largest seller was Hudson Bay Capital Management, cutting an estimated $2.27K.
- 10 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q4 2021, up from 7 in Q3 2021.
- Funds reported $4.65M of Estrella Immunopharma Warrant stock for Q4 2021, up 2.9% quarter-over-quarter.
- 3 funds opened new Estrella Immunopharma Warrant positions in Q4 2021 and 0 closed out, a net change of +3 holders.
- The largest Estrella Immunopharma Warrant buyer in Q4 2021 was Whitebox Advisors, an estimated $22.4K added.
- The largest Estrella Immunopharma Warrant seller in Q4 2021 was Hudson Bay Capital Management, an estimated $2.27K sold.
Based on aggregated 13F filings for Q4 2021.